Commercial Launch Of Liquid Biopsy Test For Lung Cancer (#GotBitcoin?)
Biocept’s Stock Soars On Heavy Volume After Commercial Launch Of Liquid Biopsy Test For Lung Cancer. Commercial Launch Of Liquid Biopsy Test For Lung Cancer (#GotBitcoin?)
Shares of Biocept Inc. BIOC, +85.37% soared 86% on very heavy volume Monday, after the provider of liquid biopsy tests announced the commercial launch of Target Selector NGS Lung Panel, the liquid biopsy panel developed for lung cancer.
Trading volume spiked to 60.9 million shares, compared with the full-day average of about 733,000 shares.
“The Target Selector™ NGS Lung Panel will be marketed to physicians and researchers, and can be used to detect and monitor actionable biomarkers associated with lung cancer,” the company said in a statement. The stock was still down 73% over the past 12 months, while the S&P 500 SPX, -0.88% has gained 4.5%.
Related Article:
He Conquered Cancer, Then 15 Spartan Races In A Year (#GotBitcoin?)
Fighting Cancer By Releasing The Brakes On The Immune System (#GotBitcoin?)
Over-Diagnosis And Over-Treatment Of Cancer In America Reaches Crisis Levels (#GotBitcoin?)
Cancer Super-Survivors Use Their Own Bodies To Fight The Disease (#GotBitcoin?)
Secrets of ‘UltraGeezer,’ Earth’s Fastest 70-Year-Old Distance Runner (#GotBitcoin?)
The Best Exercises For Your 50s, 60s, 70s—And Beyond (#GotBitcoin?)
She’s Powerlifting at 76, So You’re Officially Out of Excuses (#GotBitcoin?)
This Training Tweak Keeps Him Running At 70
33 Resistance Band Exercises You Can Do Literally Anywhere (#GotBitcoin?)
Carolyn’s Natural Organic Handmade Soap
We Now Live In A World With Customized Bar Soaps, Lotions And Shampoos (#GotBitcoin?)
Leave a Reply
You must be logged in to post a comment.